News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 325–360
- Matches
- 3436
- Sources here
- 17
- Companies here
- 28
Active search
3436 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
62,072 Shares in DICK'S Sporting Goods, Inc. $DKS Bought by SCS Capital Management LLC
SCS Capital Management LLC has acquired 62,072 shares of DICK'S Sporting Goods, Inc. (NYSE:DKS), valued at approximately $14.1 million, representing 0.07% of the company's stock. Other institutional investors have also significantly increased their holdings in DKS. Analysts maintain a "Moderate Buy" rating for DICK'S …
522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC
Renaissance Technologies LLC acquired 522,900 shares of Treace Medical Concepts, Inc. ($TMCI) in the first quarter, valued at approximately $701,000, giving them a 0.81% stake. Other institutional investors also adjusted their holdings, with hedge funds and institutions collectively owning 84.08% of the company. Despite …
Beverly Hills Private Wealth LLC Takes $3.35 Million Position in Becton, Dickinson and Company $BDX
Beverly Hills Private Wealth LLC has acquired a new position of 22,156 shares in Becton, Dickinson and Company (NYSE:BDX), valued at approximately $3.35 million. Other institutional investors also adjusted their holdings in the medical instruments supplier. The article also provides analyst ratings, stock performance …
Law firm investigates TransMedics officers for possible shareholder duty breaches
Halper Sadeh LLC is investigating whether officers and directors of TransMedics Group, Inc. (TMDX) breached their fiduciary duties to shareholders. Long-term shareholders are encouraged to seek free consultations for potential corporate governance reforms, financial incentives, or other relief. The firm emphasizes the urgency for …
FY2028 EPS Estimates for MediciNova Lowered by HC Wainwright
HC Wainwright has lowered its FY2028 EPS estimate for MediciNova to $0.28 from $0.29, although this revised estimate is still above the current consensus loss estimate. The biopharmaceutical company recently reported a quarterly loss of $0.05 per share, beating analyst expectations, with revenues also …
Fresenius Medical Care stock holds firm as market cap stays at $13.78 billion
Fresenius Medical Care (DE0005785802) stock is holding steady with a market capitalization of $13.78 billion and a share price of $25.66 as of August 2026. The stock's value is 1.26% above its year-earlier level, indicating a stable trend rather than dramatic fluctuations. The company's …
Jeffrey Silvestri to Retire as Senior Vice President, Global Head of Quality of Becton, Dickinson and Company in October 2026
Jeffrey Silvestri, Senior Vice President and Global Head of Quality at Becton, Dickinson and Company, is set to retire in October 2026 after 25 years with the company. During his tenure, Silvestri played a significant role in enhancing BD's quality framework and capabilities across …
Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18%
Avita Medical (NASDAQ: RCEL) has increased its 2026 revenue guidance to $86 million–$89 million, up from $80 million–$85 million, after a strong second quarter where sales grew 18% year-over-year to $21.7 million. The wound-care company is also on track to achieve cash-flow breakeven in …
Sharemaestro market context Trend signal active 52 weeks +52.4% · Next-week setup negative 34.9%Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds
Avita Medical (NASDAQ: RCEL) aims to achieve cash flow breakeven in Q4 2025, driven by strong revenue growth and disciplined operating expenses. The company has raised its 2025 revenue guidance to $86 million–$89 million and expects continued expansion for its wound care product portfolio, …
Sharemaestro market context Trend signal active 52 weeks +52.4% · Next-week setup negative 34.9%Kestra Medical Technologies CEO Brian Webster sells $692,214 in stock
Kestra Medical Technologies CEO Brian Webster sold $692,214 worth of company stock across three transactions between July 30 and August 3, 2026, primarily to cover tax withholding obligations related to restricted stock unit vesting. Despite these sales, Webster still beneficially owns 527,115 common shares. …
Kestra Medical Technologies officer Traci Umberger sells $512,791
Traci S. Umberger, General Counsel, Chief Administrative Officer, and Director at Kestra Medical Technologies (KMTS), sold common shares worth $512,791 to cover tax withholding obligations from restricted stock unit vesting. The sales occurred between July 30 and August 3, 2026, with share prices ranging …